A recent study has linked prolonged use of an injectable contraceptive known commonly as Depo-Provera or Sayana Press to an increased risk of meningioma.
Meningioma is a type of brain tumour involving the membranes covering the brain and spinal cord. The symptoms of this condition often involve a change in vision, hearing loss, ringing in the ears, headaches, memory loss, seizures and weakness in the arms or legs.
The Irish Health Products Regulatory Authority (HPRA) issued an urgent safety warning in October 2024 in relation to the risk of developing meningioma from prolonged use of this contraceptive. The Manufacturers of the drug, Pfizer, co-operated with the HPRA in issuing the safety information.
Background on the Safety Concerns about the contraceptive
The contraceptive is available in both injectable and oral formulations (including contraception and endometriosis.
Moloney Solicitors are currently investigating claims for compensation for those who have been affected by this condition and have been using one of these contraceptives for over a year.
Depo-Provera is injected at a GP surgery whereas Sayana Press is commonly prescribed to be self-injected at home under the skin of your abdomen or thigh. Both injections are typically required every 12-13 weeks. Although the risk of meningioma is relatively low without the contraceptive a new study found that the medicine increases the risk of meningioma by 5.6%.
If you are suffering from any of the symptoms referred to above and wish to seek legal advice in relation to how you could investigate a product liability and negligence claim, please call our office today for a no obligation discussion of your option to gain compensation and discuss your legal rights.
